Susquehanna International Group
AVNR

Susquehanna International Group’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Susquehanna International Group’s Portfolio AVNR Stock Details AVNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-158,800
Closed -$2.69M – 10585
2014
Q4 		$2.69M Sell
158,800
-212,500
-57% -$2.99M ﹤0.01% 3917
2014
Q3 		$4.43M Sell
371,300
-196,500
-35% -$1.34M ﹤0.01% 3198
2014
Q2 		$3.2M Sell
567,800
-223,000
-28% -$1.03M ﹤0.01% 3810
2014
Q1 		$2.9M Buy
790,800
+284,500
+56% +$1.08M ﹤0.01% 3705
2013
Q4 		$1.7M Buy
506,300
+484,000
+2,170% +$2M ﹤0.01% 4568
2013
Q3 		$95K Sell
22,300
-38,800
-64% -$184K ﹤0.01% 8104
2013
Q2 		$281K Buy
+61,100
New +$210K ﹤0.01% 6910

Susquehanna International Group's AVNR Position: Q1 2015 in Review

Susquehanna International Group sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 611,025 shares — an estimated $10.4M sold.

Susquehanna International Group first reported a position in AVNR in Q2 2013 and held it in 7 quarters. The position peaked at $10.4M in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

  • Susquehanna International Group reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
  • Susquehanna International Group sold 611,025 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $10.4M.
  • Susquehanna International Group first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q2 2013 and held it in 7 quarters.
  • Susquehanna International Group's AVANIR PHARMACEUTICALS, INC CL A position peaked at $10.4M in Q4 2014.
  • 0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Susquehanna International Group's 13F filing for Q1 2015, filed 15 May 2015.